Check. Change. Control. Cholesterol™ American Heart Association
-
- Health & Fitness
This podcast series for healthcare professionals offers expert insights and discussion on the prevalence of high cholesterol. Learn about improving cholesterol management with a healthy lifestyle and discuss treatment plans.
-
ASCVD Series - Part 3-The Next Top Model: Activating & Improving Systems of Care
Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.
-
ASCVD Series - Part 2-Looking Ahead in ASCVD
One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation.
-
ASCVD Series - Part 1-The Importance of Bridging the Gap in Lipid Management
How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane University to train future physicians in this subject matter.
-
Statin and Non-Statin Drugs
Statins are the cornerstone of lipid lowering drugs. Listen as Drs. Natarajan, Michos, and Kara discuss the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in 2018 AHA/ACC Cholesterol Guidelines.
-
Coronary Calcification (CAC Score)
A deep dive discussion between Drs. Pradeep Natarajan, Ron Blankstein and Khurram Nasir in assessment of Coronary artery calcium (CAC) to help guide prognosis and management. In this podcast learn the role of CAC score.
-
Uses of PCSK9 Inhibitors
Listen as Drs. Ferguson and Musunuru review history and uses of PCSK9 inhibitors and how these drugs can transform cardiovascular medicine.